| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | 0.3 | 16.0 | 888.0 | 306.7 | 5.3 | - | - | 1216.3 |
| 1 | - | - | - | - | - | 196.0 | 96.3 | 1.0 | - | - | 293.3 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 63.3 |
| 1 | 3.3 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 540.3 |
| 1 | 824.0 |
| Number of post synapses: | 3649 |
| Number of pre synapses: | 880 |
| Number of output connections: | 2738 |
| Coverage factor: | 1.9 |
| Columnar completeness: | 0.55 |
| Area completeness: | 0.73 |
| Cell size (columns): | 308 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#aMe26 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeTu1 (R) | ACh | 1,109 | 369.7 | 28.6% | 28.6% |
| 1 | Dm2 (R) | ACh | 461 | 153.7 | 11.9% | 40.5% |
| 2 | Cm3 (R) | GABA | 296 | 98.7 | 7.6% | 48.2% |
| 3 | Cm9 (R) | Glu | 262 | 87.3 | 6.8% | 54.9% |
| 4 | aMe2 (R) | Glu | 138 | 46.0 | 3.6% | 58.5% |
| 5 | MeLo3b (R) | ACh | 133 | 44.3 | 3.4% | 61.9% |
| 6 | MeVP6 (R) | Glu | 125 | 41.7 | 3.2% | 65.2% |
| 7 | MeVP14 (R) | ACh | 107 | 35.7 | 2.8% | 67.9% |
| 8 | Cm5 (R) | GABA | 100 | 33.3 | 2.6% | 70.5% |
| 9 | Tm34 (R) | Glu | 90 | 30.0 | 2.3% | 72.8% |
| 10 | Dm8a (R) | Glu | 89 | 29.7 | 2.3% | 75.1% |
| 11 | Mi15 (R) | ACh | 85 | 28.3 | 2.2% | 77.3% |
| 12 | Cm24 (R) | Glu | 72 | 24.0 | 1.9% | 79.2% |
| 13 | MeVP9 (R) | ACh | 65 | 21.7 | 1.7% | 80.8% |
| 14 | Cm4 (R) | Glu | 39 | 13.0 | 1.0% | 81.9% |
| 15 | Mi10 (R) | ACh | 37 | 12.3 | 1.0% | 82.8% |
| 16 | TmY17 (R) | ACh | 34 | 11.3 | 0.9% | 83.7% |
| 17 | MeVP45 (R) | ACh | 28 | 9.3 | 0.7% | 84.4% |
| 18 | MeLo5 (R) | ACh | 26 | 8.7 | 0.7% | 85.1% |
| 19 | MeVC7a (L) | ACh | 22 | 7.3 | 0.6% | 85.6% |
| 20 | MeVC8 (L) | ACh | 22 | 7.3 | 0.6% | 86.2% |
| 21 | MeVP8 (R) | ACh | 21 | 7.0 | 0.5% | 86.8% |
| 22 | MeVC20 (R) | Glu | 19 | 6.3 | 0.5% | 87.2% |
| 23 | MeVC_unclear (R) | Glu | 18 | 6.0 | 0.5% | 87.7% |
| 24 | MeVP20 (R) | unclear | 18 | 6.0 | 0.5% | 88.2% |
| 25 | aMe5 (R) | ACh | 17 | 5.7 | 0.4% | 88.6% |
| 26 | MeVP15 (R) | ACh | 16 | 5.3 | 0.4% | 89.0% |
| 27 | Tm5c (R) | Glu | 16 | 5.3 | 0.4% | 89.4% |
| 28 | OA-AL2i4 (R) | OA | 15 | 5.0 | 0.4% | 89.8% |
| 29 | Cm14 (R) | GABA | 14 | 4.7 | 0.4% | 90.2% |
| 30 | MeVC3 (L) | ACh | 14 | 4.7 | 0.4% | 90.6% |
| 31 | aMe1 (R) | GABA | 13 | 4.3 | 0.3% | 90.9% |
| 32 | aMe12 (R) | ACh | 13 | 4.3 | 0.3% | 91.2% |
| 33 | MeLo1 (R) | ACh | 13 | 4.3 | 0.3% | 91.6% |
| 34 | MeVC27 (L) | unclear | 13 | 4.3 | 0.3% | 91.9% |
| 35 | Cm12 (R) | GABA | 12 | 4.0 | 0.3% | 92.2% |
| 36 | Cm1 (R) | ACh | 11 | 3.7 | 0.3% | 92.5% |
| 37 | MeVPLo2 (R) | ACh | 11 | 3.7 | 0.3% | 92.8% |
| 38 | MeVPMe4 (L) | Glu | 11 | 3.7 | 0.3% | 93.1% |
| 39 | aMe4 (R) | ACh | 10 | 3.3 | 0.3% | 93.3% |
| 40 | MeTu3c (R) | ACh | 10 | 3.3 | 0.3% | 93.6% |
| 41 | aMe30 (R) | Glu | 9 | 3.0 | 0.2% | 93.8% |
| 42 | Cm25 (R) | Glu | 9 | 3.0 | 0.2% | 94.0% |
| 43 | Cm6 (R) | GABA | 9 | 3.0 | 0.2% | 94.3% |
| 44 | MeLo6 (R) | ACh | 8 | 2.7 | 0.2% | 94.5% |
| 45 | MeVP12 (R) | ACh | 8 | 2.7 | 0.2% | 94.7% |
| 46 | TmY20 (R) | ACh | 8 | 2.7 | 0.2% | 94.9% |
| 47 | 5thsLNv_LNd6 (R) | ACh | 7 | 2.3 | 0.2% | 95.1% |
| 48 | aMe6b (R) | ACh | 7 | 2.3 | 0.2% | 95.3% |
| 49 | Cm27 (R) | Glu | 7 | 2.3 | 0.2% | 95.4% |
| 50 | MeTu4c (R) | ACh | 7 | 2.3 | 0.2% | 95.6% |
| 51 | aMe26 (R) | ACh | 6 | 2.0 | 0.2% | 95.8% |
| 52 | Cm8 (R) | GABA | 6 | 2.0 | 0.2% | 95.9% |
| 53 | Dm-DRA2 (R) | Glu | 6 | 2.0 | 0.2% | 96.1% |
| 54 | Lat3 (R) | unclear | 6 | 2.0 | 0.2% | 96.2% |
| 55 | aMe23 (R) | unclear | 5 | 1.7 | 0.1% | 96.4% |
| 56 | Cm16 (R) | Glu | 5 | 1.7 | 0.1% | 96.5% |
| 57 | Cm21 (R) | GABA | 5 | 1.7 | 0.1% | 96.6% |
| 58 | Dm-DRA1 (R) | Glu | 5 | 1.7 | 0.1% | 96.7% |
| 59 | MeTu4a (R) | ACh | 5 | 1.7 | 0.1% | 96.9% |
| 60 | Cm23 (R) | Glu | 4 | 1.3 | 0.1% | 97.0% |
| 61 | Cm30 (R) | GABA | 4 | 1.3 | 0.1% | 97.1% |
| 62 | MeVP33 (R) | ACh | 4 | 1.3 | 0.1% | 97.2% |
| 63 | MeVPOL1 (R) | ACh | 4 | 1.3 | 0.1% | 97.3% |
| 64 | Tm5a (R) | ACh | 4 | 1.3 | 0.1% | 97.4% |
| 65 | aMe12 (L) | ACh | 3 | 1.0 | 0.1% | 97.5% |
| 66 | aMe15 (R) | unclear | 3 | 1.0 | 0.1% | 97.5% |
| 67 | aMe22 (R) | Glu | 3 | 1.0 | 0.1% | 97.6% |
| 68 | Cm10 (R) | GABA | 3 | 1.0 | 0.1% | 97.7% |
| 69 | Cm18 (R) | Glu | 3 | 1.0 | 0.1% | 97.8% |
| 70 | Cm31b (R) | GABA | 3 | 1.0 | 0.1% | 97.9% |
| 71 | Cm33 (R) | GABA | 3 | 1.0 | 0.1% | 97.9% |
| 72 | Lat1 (R) | unclear | 3 | 1.0 | 0.1% | 98.0% |
| 73 | Li29 (R) | GABA | 3 | 1.0 | 0.1% | 98.1% |
| instance | NT | total connections | connections /#aMe26 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm3 (R) | GABA | 842 | 280.7 | 29.9% | 29.9% |
| 1 | Cm12 (R) | GABA | 509 | 169.7 | 18.1% | 48.0% |
| 2 | Cm8 (R) | GABA | 152 | 50.7 | 5.4% | 53.4% |
| 3 | MeVC27 (L) | unclear | 146 | 48.7 | 5.2% | 58.6% |
| 4 | Mi17 (R) | GABA | 113 | 37.7 | 4.0% | 62.6% |
| 5 | Cm6 (R) | GABA | 109 | 36.3 | 3.9% | 66.5% |
| 6 | Cm16 (R) | Glu | 99 | 33.0 | 3.5% | 70.0% |
| 7 | Dm2 (R) | ACh | 80 | 26.7 | 2.8% | 72.9% |
| 8 | Tm37 (R) | Glu | 72 | 24.0 | 2.6% | 75.4% |
| 9 | MeVP9 (R) | ACh | 54 | 18.0 | 1.9% | 77.4% |
| 10 | Cm5 (R) | GABA | 50 | 16.7 | 1.8% | 79.1% |
| 11 | MeTu4c (R) | ACh | 44 | 14.7 | 1.6% | 80.7% |
| 12 | MeVP59 (R) | ACh | 41 | 13.7 | 1.5% | 82.2% |
| 13 | Lat3 (R) | unclear | 40 | 13.3 | 1.4% | 83.6% |
| 14 | OA-AL2i4 (R) | OA | 37 | 12.3 | 1.3% | 84.9% |
| 15 | Cm4 (R) | Glu | 32 | 10.7 | 1.1% | 86.0% |
| 16 | Tm34 (R) | Glu | 29 | 9.7 | 1.0% | 87.1% |
| 17 | Tm5c (R) | Glu | 29 | 9.7 | 1.0% | 88.1% |
| 18 | MeVPaMe2 (R) | Glu | 22 | 7.3 | 0.8% | 88.9% |
| 19 | Tm35 (R) | Glu | 19 | 6.3 | 0.7% | 89.5% |
| 20 | aMe4 (R) | ACh | 18 | 6.0 | 0.6% | 90.2% |
| 21 | MeVPLo2 (R) | ACh | 18 | 6.0 | 0.6% | 90.8% |
| 22 | MeTu1 (R) | ACh | 15 | 5.0 | 0.5% | 91.4% |
| 23 | Mi10 (R) | ACh | 15 | 5.0 | 0.5% | 91.9% |
| 24 | MeVP45 (R) | ACh | 13 | 4.3 | 0.5% | 92.4% |
| 25 | MeVP55 (R) | unclear | 13 | 4.3 | 0.5% | 92.8% |
| 26 | 5thsLNv_LNd6 (R) | ACh | 12 | 4.0 | 0.4% | 93.2% |
| 27 | MeVC20 (R) | Glu | 11 | 3.7 | 0.4% | 93.6% |
| 28 | Cm22 (R) | GABA | 9 | 3.0 | 0.3% | 94.0% |
| 29 | MeVPMe12 (R) | ACh | 9 | 3.0 | 0.3% | 94.3% |
| 30 | Cm11c (R) | ACh | 7 | 2.3 | 0.2% | 94.5% |
| 31 | 5-HTPMPV03 (R) | 5HT | 6 | 2.0 | 0.2% | 94.7% |
| 32 | aMe26 (R) | ACh | 6 | 2.0 | 0.2% | 95.0% |
| 33 | MeTu4a (R) | ACh | 6 | 2.0 | 0.2% | 95.2% |
| 34 | MeVPMe5 (R) | Glu | 6 | 2.0 | 0.2% | 95.4% |
| 35 | Mi15 (R) | ACh | 6 | 2.0 | 0.2% | 95.6% |
| 36 | SLP250 (R) | unclear | 6 | 2.0 | 0.2% | 95.8% |
| 37 | Cm30 (R) | GABA | 5 | 1.7 | 0.2% | 96.0% |
| 38 | MeLo5 (R) | ACh | 5 | 1.7 | 0.2% | 96.2% |
| 39 | MeVP6 (R) | Glu | 5 | 1.7 | 0.2% | 96.3% |
| 40 | Cm1 (R) | ACh | 4 | 1.3 | 0.1% | 96.5% |
| 41 | l-LNv (R) | unclear | 4 | 1.3 | 0.1% | 96.6% |
| 42 | MeLo6 (R) | ACh | 4 | 1.3 | 0.1% | 96.8% |
| 43 | MeTu3b (R) | ACh | 4 | 1.3 | 0.1% | 96.9% |
| 44 | MeVP49 (R) | unclear | 4 | 1.3 | 0.1% | 97.0% |
| 45 | Mi16 (R) | GABA | 4 | 1.3 | 0.1% | 97.2% |
| 46 | 5-HTPMPV03 (L) | 5HT | 3 | 1.0 | 0.1% | 97.3% |
| 47 | Cm-DRA (R) | ACh | 3 | 1.0 | 0.1% | 97.4% |
| 48 | Cm10 (R) | GABA | 3 | 1.0 | 0.1% | 97.5% |
| 49 | SLP249 (R) | unclear | 3 | 1.0 | 0.1% | 97.6% |
| 50 | TmY10 (R) | ACh | 3 | 1.0 | 0.1% | 97.7% |